Lispro NL-ELISA (10-1291-01)

Mercodia Lispro NL-ELISA is designed to be an excellent assay for pharma use. It provides a chemiluminescent method for the quantitative determination of insulin lispro. Kit format: 1 x 96 wells Measurement range: 1 – 500 mU/L Optimized for pharma use No cross-reactivity to endogenous insulin or other insulin analogs e.g. glargine No interference from insulin auto-antibodies Fully validated for use with human and pig samples, partially validated for rat samples Controls included in the kit Test Characteristics Samples: human and porcine serum, EDTA plasma and P-800 plasma Sample volume: 10 µL Assay range: 1 – 500 mU/L Detection limit: 0.36 mU/L Incubation: 1h + 1h + 10 min Detection method: Chemiluminescence Specificity The following cross-reactions and interferences were studied: Human insulin N.D. Human proinsulin N.D. Glargine N.D. Glargine M1 N.D. Glargine M2 N.D. Degludec N.D. Determir N.D. Insulin NPH N.D. Aspart N.D. Glulisine N.D. Porcine insulin N.D. Porcine proinsulin N.D. N.D. = Not Detected

For more information on Lispro NL-ELISA (10-1291-01) talk to Diagenics Ltd